Opendoor Technologies Inc vs Health Care Select Sector SPDR Fund — how do they compare? Opendoor Technologies Inc trades at $2.33 (market cap $2.20B), while Health Care Select Sector SPDR Fund trades at $168.75 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 19.6× Opendoor Technologies Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Opendoor Technologies Inc for 33 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| OPEN | XLV | |
|---|---|---|
Market Cap | $2.20B | $43.11B |
Volume | 35,582,488 | 8,870,090 |
Sector | Real Estate | — |
52-Week High | $9.37 | $175.68 |
52-Week Low | $2.27 | $141.95 |
Typical Hold Time | 33 Days | 100 Days |
Enterprise Value | $3.27B | — |
Signals from Pluang's Aura AI — not financial advice
Opendoor Technologies trades at $2.29, up 0.88% with a bearish technical outlook. The company shows concerning fundamentals with a -46.74% net income margin and -$1.3B net loss despite $4.37B revenue. Recent earnings misses and negative cash flow trends highlight operational challenges, though mortgage expansion to 35-40 states by end-2026 offers potential growth. Analyst consensus is mixed with 26.9% buy ratings but a $4.92 price target suggesting 115% upside from current levels.
The stock presents high-risk speculative potential with significant operational turnaround required. While valuation appears attractive at 0.62 P/S ratio, persistent losses and housing market sensitivity create substantial downside risk. The mortgage expansion initiative could drive recovery if execution improves, but investors face volatility from rate sensitivity and competitive pressures in the iBuyer space.
XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.
XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →